IP Library › Assignment 027618/0021
Patent Assignment
Reel/Frame 027618/0021

Assignment of Assignor's Interest

Recorded: 2012-01-30 Pages: 3
Assignor
SIRBASKU, DAVID A
Executed: 2012-01-26
Assignee
SIGNE BIOPHARMA INC.
1717 W. WALNUT HILL LANE, SUITE 104, IRVING, TEXAS, 75038
Covered Property (1)
Anti-Estrogen and Immune Modulator Combinations for Treating Breast Cancer
Patent: 8,119,138 →
Application: 10/293,439 →
Publication: US 2003/0072760
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 10, 2003
From: UNIVERSITY OF TEXAS SYSTEMS, THE
To: SIRBASKU, DAVID A.
Reel/Frame 013737/0951 →
Confirmatory Licenses for Government Register Apr 22, 2004
From: KAYLONE BIOPHARMACEUTICALS
To: UNITED STATES GOVERNMENT SECRETARY OF THE ARMY, THE
Reel/Frame 015233/0181 →
Assignment of Assignor's Interest Feb 19, 2007
From: SIRBASKU, DAVID A., PHD
To: SIGNE BIOPHARMA INC.
Reel/Frame 018902/0870 →
Change of Assignee Address Sep 5, 2007
From: SIGNE BIOPHARMA INC.
To: SIGNE BIOPHARMA INC.
Reel/Frame 019785/0099 →